IP Verse

Botti & Ferrari patent opposition analysis

The comprehensive analysis of Botti & Ferrari opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Botti & Ferrari

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3700529	New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)	BOEHRINGER INGELHEIM	Apr 9, 2026	BOTTI & FERRARI
EP4316598	Pharmaceutical Composition Containing Poorly-Soluble Basic Medicine	CHUGAI SEIYAKU KABUSHIKI KAISHA	Mar 17, 2026	BOTTI & FERRARI
EP4294395	Treatment Of Breast Cancer Using Combination Therapies Comprising Gdc-9545 And Gdc-0077	GENENTECH	Dec 29, 2025	BOTTI & FERRARI
EP3615541	Polymorphs And Solid Forms Of (S)-2-((2-((S)-4-(Difluoromethyl)-2-Oxooxazolidin-3-Yl)-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepin-9-Yl)Amino)Propanamide, And Methods Of Production	F HOFFMANN LA ROCHE	Dec 19, 2025	BOTTI & FERRARI
EP3246047	Combination Drug	CHUGAI SEIYAKU KABUSHIKI KAISHA	Sep 24, 2025	BOTTI & FERRARI
EP4069254	Combination Decitabine And Cedazuridine Solid Oral Dosage Forms	OTSUKA PHARMACEUTICAL	Jun 11, 2025	BOTTI & FERRARI
EP3595667	Pharmaceutical Compositions Comprising A Jak Inhibitor	GILEAD SCIENCES	Sep 17, 2024	BOTTI & FERRARI
EP3526170	Method For Producing Mineral Fibres	SAINT GOBAIN	Sep 6, 2024	STM
EP2497650	Method For Processing A Structured Surface Of An Embossing Tool	HUECK RHEINISCHE	Jul 11, 2024	SESA
EP3500241	Combination Therapy For Copd	CHIESI FARMACEUTICI	Jul 3, 2024	BOTTI & FERRARI

Top companies who are the clients of Botti & Ferrari